ASTRO releases first cervical cancer guidelines
June 12, 2020 -- The American Society for Radiation Oncology (ASTRO) has released its first clinical guidelines for radiation therapy to treat patients with nonmetastatic cervical cancer. The guidelines were published in Practical Radiation Oncology.
Discuss
June 12, 2020 -- The American Society for Radiation Oncology (ASTRO) has released its first clinical guidelines for radiation therapy to treat patients with nonmetastatic cervical cancer. The guidelines were published in Practical Radiation Oncology.
Discuss Radiation therapist job openings increase
June 4, 2020 -- The vacancy rate for radiation therapists reached 7.2% in 2020, a significant increase from the 3.2% vacation rate in 2018, according to a new survey from the American Society of Radiologic Technologists performed prior to the COVID-19 pandemic.
June 4, 2020 -- The vacancy rate for radiation therapists reached 7.2% in 2020, a significant increase from the 3.2% vacation rate in 2018, according to a new survey from the American Society of Radiologic Technologists performed prior to the COVID-19 pandemic.
RefleXion to collaborate with Merck on clinical trial
May 29, 2020 -- Radiation therapy equipment developer RefleXion Medical has announced a clinical collaboration with Merck to evaluate the safety and efficacy of Keytruda in combination with RefleXion's biology-guided radiotherapy in multiple late-stage cancers, including non-small cell lung cancer.
May 29, 2020 -- Radiation therapy equipment developer RefleXion Medical has announced a clinical collaboration with Merck to evaluate the safety and efficacy of Keytruda in combination with RefleXion's biology-guided radiotherapy in multiple late-stage cancers, including non-small cell lung cancer.
RaySearch, Varian partner to track radiation therapy
May 28, 2020 -- Radiation therapy software developer RaySearch Laboratories and radiation oncology firm Varian Medical Systems have entered into an agreement to help patients track radiation treatment progress.
May 28, 2020 -- Radiation therapy software developer RaySearch Laboratories and radiation oncology firm Varian Medical Systems have entered into an agreement to help patients track radiation treatment progress.
Years later, DCIS tied to more imaging but not anxiety
May 26, 2020 -- In the five years after treatment, women with a history of ductal carcinoma in situ (DCIS) are more likely than their peers to undergo breast imaging but not to have anxiety or depression, according to the findings of a study published on May 8 in Breast Cancer Research and Treatment.
Discuss
May 26, 2020 -- In the five years after treatment, women with a history of ductal carcinoma in situ (DCIS) are more likely than their peers to undergo breast imaging but not to have anxiety or depression, according to the findings of a study published on May 8 in Breast Cancer Research and Treatment.
Discuss Varian adds COVID-19 screening to Noona app
May 22, 2020 -- Radiation therapy vendor Varian Medical Systems has added new features to its Noona oncology reporting and patient monitoring mobile application that support the screening of patients for COVID-19.
May 22, 2020 -- Radiation therapy vendor Varian Medical Systems has added new features to its Noona oncology reporting and patient monitoring mobile application that support the screening of patients for COVID-19.
Survey: COVID-19 negatively affects radiation clinics
May 20, 2020 -- Eighty-five percent of radiation oncology clinics responding to a survey experienced a drop in the number of patients they saw in April despite quickly implementing safety enhancements during the pandemic, according to data from the American Society for Radiation Oncology.
May 20, 2020 -- Eighty-five percent of radiation oncology clinics responding to a survey experienced a drop in the number of patients they saw in April despite quickly implementing safety enhancements during the pandemic, according to data from the American Society for Radiation Oncology.
Blue Earth highlights PET agent clinical results
May 19, 2020 -- Bracco molecular imaging subsidiary Blue Earth Diagnostics is highlighting clinical results from a German study using PET/CT and its radiohybrid prostate-specific membrane antigen-targeted compound for prostate cancer.
May 19, 2020 -- Bracco molecular imaging subsidiary Blue Earth Diagnostics is highlighting clinical results from a German study using PET/CT and its radiohybrid prostate-specific membrane antigen-targeted compound for prostate cancer.
GenesisCare closes 21st Century Oncology acquisition
May 15, 2020 -- Australian cancer and cardiac care company GenesisCare has closed the previously announced acquisition of U.S.-based radiation therapy and integrated cancer treatment provider 21st Century Oncology.
May 15, 2020 -- Australian cancer and cardiac care company GenesisCare has closed the previously announced acquisition of U.S.-based radiation therapy and integrated cancer treatment provider 21st Century Oncology.
MITA joins coalition to lobby for COVID-19 relief
May 12, 2020 -- The Medical Imaging and Technology Alliance (MITA) has joined with a number of imaging organizations to lobby congressional leaders for direct financial support to radiology providers to be included in the next COVID-19 legislative relief package.
May 12, 2020 -- The Medical Imaging and Technology Alliance (MITA) has joined with a number of imaging organizations to lobby congressional leaders for direct financial support to radiology providers to be included in the next COVID-19 legislative relief package.
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT